John Christie

John Christie, Ph.D., currently serves as a Scientist II at Candel Therapeutics since November 2022. Prior to this role, John worked as a Postdoctoral Researcher at Harvard Medical School from November 2021 to November 2022. John earned a Doctor of Philosophy in Virology from Arizona State University, where studies were completed between January 2017 and November 2021. Additionally, John holds a Master's degree in Neurobiology and Neurosciences and a Bachelor of Science in Biological and Biomedical Sciences, both obtained from Western Michigan University.